EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Association between iatrogenic atrial septal shunt VTI and clinical outcomes after mitral transcatheter edge-to-edge repair

Itshak Amsalem, Efrat Shemesh, Hodaya Denekamp, Michael Glikson, Shemy Carasso, Mony Shuvy

Frontiers in Cardiovascular Medicine · 2026-11-10 · 13

DOI: 10.3389/fcvm.2026.1969083 ↗
AbstractBibliografische Angaben

Abstract

Background Transseptal access during mitral transcatheter edge-to-edge repair (M-TEER) creates an iatrogenic atrial septal defect (iASD), but the prognostic significance of its flow remains uncertain. We evaluated intraprocedural net velocity-time integral (VTI) as a Doppler measure of directional iASD flow velocity, not shunt volume. Methods This retrospective single-center study included patients undergoing M-TEER between 2021–2023. Net Doppler VTI was calculated as left-to-right minus right-to-left VTI; the primary analysis included positive values. The primary outcome was all-cause mortality or heart-failure hospitalization at 6, 12, and 24 months. Results Among 160 patients, median net VTI was 27.75 cm (IQR, 20.2–40.0). Composite–event rates were 36.6%, 49.6%, and 61.4% at 6, 12, and 24 months, respectively. Adjusted analyses identified no statistically significant association of VTI with the composite outcome at 6 months (OR per 10-cm increase 0.99; 95% CI 0.81–1.21), 12 months (OR 1.01; 95% CI 0.83–1.22), or 24 months (OR, 1.09; 95% CI, 0.89–1.34). Findings were consistent across categorical, spline, and directional-component analyses, without an identified outcome-associated threshold. Baseline tricuspid regurgitation (TR) was available in 133 patients. Exploratory TR-VTI interaction analyses were not statistically significant at 6, 12, or 24 months ( P = 0.595, 0.691, and 0.669, respectively). Conclusions Among patients with predominantly left-to-right shunting after M-TEER, no statistically significant association was identified between intraprocedural net iASD VTI and mortality or heart-failure hospitalization overall.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →